| ²é¿´: 1300 | »Ø¸´: 6 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
ÖÐÒëÓ¢£¨Ò©´ú·½ÃæµÄ£©
|
|||
|
¶à¼ÁÁ¿¿Ú·þ10mgÁ½ÖÖÖÆ¼Á£¬Ã¿ÈÕÒ»´Î£¬Ã¿´Î10mg£¬ÓÚ·þÒ©ºóµÚ4ÌìѪҩŨ¶È´ïÎÈ̬¡£Á½ÖÖÖÆ¼ÁµÄFֵΪ98.9%¡À7.9%£¬²ÎÊýTmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT£¬FIµÈÖ÷ÒªÒ©´ú²ÎÊý½Ó½ü£¬¾·½²îÏÔʾÎÞÏÔÖøÐÔ²îÒ죬½øÒ»²½¾Ë«µ¥²àt¼ìÑéºÍ£¨1-2a£©ÖÃÐÅÇø¼ä·ÖÎöÏÔʾҩ´ú¶¯Á¦Ñ§²ÎÊý½ÓÊÜÉúÎïµÈЧÐÔ¼ÙÉ裬˵Ã÷Á½ÖÖÖÆ¼ÁµÈЧ¡£ ÁÙ´²¹Û²ì£¬ÊÔÑéÆÚ¼äδ¼û²»Á¼·´Ó¦£¬ÎÞÖÐ;ÖÕÖ¹ÊÔÑéµÄÊÜÊÔÕß¡£ ÌåÄÚÍâÏà¹ØÐÔ ÌåÍâÈܳöÊý¾Ý ÒÀ¾ÝÑÐÖÆµ¥Î»Öƶ¨µÄÊͷŶȷ½·¨²â¶¨ÊÔÑ黺ÊͽºÄÒµÄÌåÍâÈܳöÊý¾ÝÈç±í ÌåÄÚÎüÊÕÊý¾Ý ÒÔWanger-Nelson·¨¼ÆËãÊÔÑéÓûºÊͽºÄÒ²»Í¬Ê±¼äµÄÌåÄÚÎüÊÕÊý¾Ý£¬½á¹ûÈç±í ÌåÄÚÎüÊÕÊý¾ÝÓëÌåÍâÈܳö·ÖÊýµÄÏà¹ØÐÔÁ¼ºÃ£¬Ïà¹Ø·½³ÌÈçÏ£º ÌåÄÚÎüÊÕÁ¿%=1.455*ÌåÍâÈܳöÁ¿-12.23 r=0.9638 |
» ²ÂÄãϲ»¶
309Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸±±½»²ÄÁϹ¤³Ì×Ü·Ö358
ÒѾÓÐ7È˻ظ´
311Çóµ÷¼ÁÒ»Ö¾Ô¸ºÏ·Ê¹¤Òµ´óѧ
ÒѾÓÐ14È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ4È˻ظ´
085602»¯Ñ§¹¤³Ì268·Ö¶×µ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ11È˻ظ´
²ÄÁÏר˶306Ó¢Ò»Êý¶þ
ÒѾÓÐ6È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÖйúʯÓÍ´óѧ£¨±±¾©£© »¯Ñ§¹¤³ÌרҵÕÐ2026¼¶²©Ê¿
+1/485
»¶Ó±¨¿¼¸ÓÄÏʦ·¶´óѧÖÇÄÜÖÆÔìÓëδÀ´ÄÜԴѧԺ
+2/144
2026Äê¸ÓÄÏʦ·¶´óѧ½ÓÊÕ µç×ÓÐÅÏ¢¹¤³Ì+»¯Ñ§+²ÄÁÏÓ뻯¹¤×¨Òµ µ÷¼ÁѧÉú
+1/87
Ìì½òÀí¹¤´óѧ¹¦Äܾ§ÌåÑо¿Ôº£¨¾§Ìå²ÄÁÏÈ«¹úÖØµãʵÑéÊÒ£©½ÜÇàÍŶÓÕÐÊÕ2026Äê˶ʿÑо¿Éú
+1/39
ÎåÒØ´óѧ»·¾³Ó뻯ѧ¹¤³ÌѧԺÏȽøÓлú¸ß·Ö×Ó²ÄÁÏÍŶÓ
+1/35
2026ÖÐɽ´óѧËïÒÝÏɼÍÄîÒ½ÔºÁõÕ×Óî¿ÎÌâ×éÕÐÊÕµ÷¼Á˶ʿÑо¿Éú
+1/35
¹þ¶û±õ¹¤Òµ´óѧÉîÛÚ ½ðÊôÔö²ÄÖÆÔì·½Ïò²©Ê¿ÕÐÉú
+1/33
2023ÄêÄϾ©ÁÖÒµ´óѧ£¨Ë«Ò»Á÷ѧ¿Æ½¨Éè¸ßУ£©»¯¹¤Ñ§ÔºÕÐÉú»¯¹¤·½Ïòµ÷¼ÁÉú
+1/32
²ÄÁÏ/»¯Ñ§/»·¾³ 5-10ÈËר˶, AÀàÏߣ¬Î人·ÄÖ¯´óѧ²ÄÁÏѧԺ£¬ÄÜÔ´¸ß·Ö×Ó·½Ïò
+1/17
ÖØÇ칤ÉÌ´óѧ ½ÌÓý²¿Ñо¿ÖÐÐÄÕÐÊÕ»¯¹¤/»·¾³/²ÄÁÏ/ʯÓÍ/»úе·½Ïò2026Äêµ÷¼ÁÑо¿Éú
+1/16
¹ã¶«¹¤Òµ´óѧ»úµç¹¤³ÌѧԺ¸ßΰ½ÌÊÚÕÐÊÕ²©Ê¿Éú
+1/11
²©Ê¿ÕÐÉú | Çൺ¿Æ¼¼´óѧ£¨¸ß·Ö×Ó¡¢»¯Ñ§¡¢²ÄÁÏ¡¢Á¦Ñ§¡¢º½Ìì¡¢»úµç¹¤³Ì¡¢¼ÆËã»ú·ÂÕæ£©
+1/10
ÑĮ̀´óѧ»·¾³Óë²ÄÁϹ¤³ÌѧԺÏȽø´¢ÄܲÄÁÏÓëÆ÷¼þ¿ÎÌâ×éÕÐÊÕ²ÄÁÏ·½Ïò˶ʿ
+2/10
¡¾²©Ê¿ÕÐÉú¡¿Î人¿Æ¼¼´óѧÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀà2026Äê¡°ÉêÇë-¿¼ºË¡±ÖƲ©Ê¿Éú
+1/8
¹þ¶û±õ¹¤³Ì´óѧ¶¯Á¦Ñ§ÔºÕÔ½¨»ÔÍŶÓÕÐÊÕ2026²©Ê¿Ñо¿Éú
+1/6
Ë«·ÇÓоÑéÖ®ÈËÇóµ÷¼Á
+1/4
ÖØÇ콻ͨ´óѧ¿ÎÌâ×é½ÓÊÕµ÷¼ÁÉú£¨²ÄÁÏÓ뻯¹¤/²ÄÁÏ¿ÆÑ§Ó빤³Ì/½»Í¨ÔËÊä/½»Í¨ÔËÊ乤³Ì£©
+1/4
Õ㽸ßУ×ÊÔ´Óë»·¾³Ë¶Ê¿µ÷¼ÁÃû¶î³ä×㣬¹ý¹ú¼ÒAÇøÏß¿ÉÉêÇë
+1/3
2026Äê Î人·ÄÖ¯´óѧ ¼¼ÊõÑо¿Ôº ·ÄÖ¯ÏËά¼°ÖÆÆ·½ÌÓý²¿ÖصãʵÑéÊÒ ½ÓÊÕµ÷¼ÁÑо¿Éú£¡
+1/1
ÖйúÃñº½·ÉÐÐѧԺÏȽøÁ¬½ÓÍŶÓÕÐÊÕº½¿ÕÓ¡¢º½¿Õ»úеרҵ˶ʿÑо¿Éú£¨Ñ§Ë¶×¨Ë¶¾ù¿É£©
+1/1
°®ÓëÓêÏÂ
гæ
- ·ÒëEPI: 283
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ¹ó±ö: 3.592
- ½ð±Ò: 33341.6
- Ìû×Ó: 4644
- ÔÚÏß: 1456.1Сʱ
- ³æºÅ: 535832
ÏÄÌìÏÂÓêÁË(½ð±Ò+1, ·ÒëEPI+1): 2011-03-09 14:54:20
wg423(·ÒëEPI-1): ·ÇÓ¦Öú£¬ÊÕ»ØEPI 2011-03-09 15:29:29
wg423(·ÒëEPI-1): ·ÇÓ¦Öú£¬ÊÕ»ØEPI 2011-03-09 15:29:29
|
ÌåÄÚÍâÏà¹ØÐÔ ÌåÍâÈܳöÊý¾Ý correlation in vivo dissolution data in vitro |
2Â¥2011-03-09 12:29:04
°®ÓëÓêÏÂ
ÎÞ³æ
- ·ÒëEPI: 283
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ¹ó±ö: 3.592
- ½ð±Ò: 33341.6
- Ìû×Ó: 4644
- ÔÚÏß: 1456.1Сʱ
- ³æºÅ: 535832
3Â¥2011-03-09 12:30:25
4Â¥2011-03-09 14:54:01
5Â¥2011-03-09 16:18:20
ÏÄÌìÏÂÓêÁË(½ð±Ò+18, ·ÒëEPI+1): лл 2011-03-09 18:10:02
|
¶à¼ÁÁ¿¿Ú·þ10mgÁ½ÖÖÖÆ¼Á£¬Ã¿ÈÕÒ»´Î£¬Ã¿´Î10mg£¬ÓÚ·þÒ©ºóµÚ4ÌìѪҩŨ¶È´ïÎÈ̬¡£Á½ÖÖÖÆ¼ÁµÄFֵΪ98.9%¡À7.9%£¬²ÎÊýTmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT£¬FIµÈÖ÷ÒªÒ©´ú²ÎÊý½Ó½ü£¬¾·½²îÏÔʾÎÞÏÔÖøÐÔ²îÒ죬½øÒ»²½¾Ë«µ¥²àt¼ìÑéºÍ£¨1-2a£©ÖÃÐÅÇø¼ä·ÖÎöÏÔʾҩ´ú¶¯Á¦Ñ§²ÎÊý½ÓÊÜÉúÎïµÈЧÐÔ¼ÙÉ裬˵Ã÷Á½ÖÖÖÆ¼ÁµÈЧ¡£ Two preparations were oral administrated once per day and 10mg per time. Plasma concentration reached steady state at the fourth day after administration. F value for two preparations was 98.9%¡À7.9%, ANOVA analysis showed no significant differences between two preparations on Tmax£¬Cmax£¬Cmin£¬AUCss£¬AUMCss£¬MRT and FI. Further analysis by two- tailed T-test and (1-2a) confidential interval suggested that pharmacokinetic parameters of two preparations were comparable. ÁÙ´²¹Û²ì£¬ÊÔÑéÆÚ¼äδ¼û²»Á¼·´Ó¦£¬ÎÞÖÐ;ÖÕÖ¹ÊÔÑéµÄÊÜÊÔÕß¡£ No side effects were found during the trial. No subjects quit. ÌåÄÚÍâÏà¹ØÐÔ Correlation between in vitro dissolution and in vivo absorption ÌåÍâÈܳöÊý¾Ý In vitro dissolution test ÒÀ¾ÝÑÐÖÆµ¥Î»Öƶ¨µÄÊͷŶȷ½·¨²â¶¨ÊÔÑ黺ÊͽºÄÒµÄÌåÍâÈܳöÊý¾ÝÈç±í In vitro dissolution test of sustained release capsule was carried out according to the dilution method provided by the producing company. The data was shown in table 1. ÌåÄÚÎüÊÕÊý¾Ý In vivo absorption study ÒÔWanger-Nelson·¨¼ÆËãÊÔÑéÓûºÊͽºÄÒ²»Í¬Ê±¼äµÄÌåÄÚÎüÊÕÊý¾Ý£¬½á¹ûÈç±í ÌåÄÚÎüÊÕÊý¾ÝÓëÌåÍâÈܳö·ÖÊýµÄÏà¹ØÐÔÁ¼ºÃ£¬Ïà¹Ø·½³ÌÈçÏ£º ÌåÄÚÎüÊÕÁ¿%=1.455*ÌåÍâÈܳöÁ¿-12.23 r=0.9638 In vivo absorptions in different time were examined by Wanger-Nelson method. Absorption data were shown in table 2. In vitro dissolution and in vivo absorption were well correlated (In vivo absorption%=1.455* In vitro dissolution-12.23, r=0.9638) |
6Â¥2011-03-09 17:19:44
7Â¥2011-03-09 18:08:13














»Ø¸´´ËÂ¥